| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d380910291671dc2738927a425603ad0 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-368
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-387
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y10S436-817
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y10S436-811 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-566
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-743
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-76
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G16H10-40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B10-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-53
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G16H50-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-689 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-68
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G16H10-40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G16H50-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-53
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-50
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-76
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-74 |
| filingDate |
1995-08-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ba4608fce42a15e4966ebc57fdf47ec9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ec8c361d40ca8a4040f8cf4450705b74
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_15fdae65d33443c07338c3a66bea4f51 |
| publicationDate |
1996-03-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-0701131-A2 |
| titleOfInvention |
Antenatal screening for pregnancy abnormalities |
| abstract |
There is disclosed a method of antenatal screening for pregnancy abnormalities in which a sample of maternal body fluid from a pregnant woman is measured for the level of at least one marker and/or a precursor or metabolite of said marker and the measured level of this marker together with the gestational age of the woman are compared with reference values at various gestational ages of the level for the marker in (a) pregnant women carrying foetuses having abnormality(s) subject to the screen and/or (b) pregnant women carrying normal foetuses, the comparison being indicative of the risk of the pregnant woman carrying a foetus with an abnormality subject to the screen characterised in that the marker is dimeric inhibin. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0800085-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2005090995-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9802751-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6620590-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5906944-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2005090995-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0800085-A3 |
| priorityDate |
1994-08-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |